
Announcement on Voluntary Disclosure of the Subsidiary's YKYY036 Injection Obtaining Clinical Trial Approvals from the National Medical Products Administration and the U.S. Food and Drug Administration
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
